Type 1 diabetes and multiple sclerosis - A Danish population-based cohort study

被引:93
|
作者
Nielsen, Nete M.
Westergaard, Tine
Frisch, Morten
Rostgaard, Klaus
Wohlfahrt, Jan
Koch-Henriksen, Nils
Melbye, Mads
Hjalgrim, Henrik
机构
[1] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark
[2] Natl Inst Publ Hlth, Copenhagen, Denmark
[3] Aarhus Univ Hosp, Dept Neurol, Aalborg, Denmark
[4] Natl Univ Hosp, Danish Register Multiple Sclerosis, Copenhagen, Denmark
关键词
D O I
10.1001/archneur.63.7.1001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Type 1 diabetes mellitus (T1D) and multiple sclerosis (MS) contribute considerably to the burden of autoimmune diseases in young adults. Although HLA patterns of T1D and MS are considered mutually exclusive, individual and familial co-occurrence of the 2 diseases has been reported. Objective: To assess the co-occurrence of T1D and MS by estimating the risk for MS in patients with T1D and the risk for T1D in first-degree relatives of patients with MS. Design, Setting, and Participants: Two populationbased disease registers, the Danish Hospital Discharge Register and the Danish Multiple Sclerosis Register were used to identify patients with T1D, defined as patients in whom diabetes was diagnosed before age 20 years (N = 6078), and patients with MS (N = 11 862). Firstdegree relatives (N = 14 771) of patients with MS were identified from family information in the Danish Civil Registration System. Main Outcome Measure: Patients with T1D and first-degree relatives of patients with MS were followed up for occurrence of MS and T1D, respectively, and the relative risks were expressed as standardized incidence ratios, that is, ratios of observed to expected numbers of outcomes based on national age, sex, and period-specific MS and T1D incidence rates. Results: Patients with T1D were at more than 3-fold increased risk for development of MS (relative risk, 3.26; 95% confidence interval, 1.80-5.88; n = 11). First-degree relatives of patients with MS were at 63% increased risk (relative risk, 1.63; 95% confidence interval, 1.26-2.12; n = 56) for development of T1D. However, adjusting for familial relationship to patients with T1D reduced the excess risk to 44% (relative risk, 1.44; 95% confidence interval, 1.11-1.88; n = 56). Conclusion: The present nationwide cohort study demonstrates an intraindividual and, to a lesser degree, an intrafamilial co-occurrence of MS and T1D.
引用
收藏
页码:1001 / 1004
页数:4
相关论文
共 50 条
  • [1] Ocrelizumab treatment in multiple sclerosis - a Danish population-based cohort study
    Pontieri, L.
    Blinkenberg, M.
    Bramow, S.
    Papp, V.
    Rasmussen, P. V.
    Kant, M.
    Schafer, J.
    Mathiesen, H. K.
    Jensen, M. B.
    Sirakov, G.
    Berg, J. M.
    Kopp, T. I.
    Joensen, H.
    Sellebjerg, F.
    Magyari, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 676 - 677
  • [2] Ocrelizumab treatment in multiple sclerosis: A Danish population-based cohort study
    Pontieri, Luigi
    Blinkenberg, Morten
    Bramow, Stephan
    Papp, Viktoria
    Rasmussen, Peter, V
    Kant, Matthias
    Schaefer, Jakob
    Mathiesen, Henrik K.
    Jensen, Michael B.
    Sirakov, Georgi
    Berg, Jonas M.
    Kopp, Tine, I
    Joensen, Hanna
    Sellebjerg, Finn
    Magyari, Melinda
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (02) : 496 - 504
  • [3] Hormone therapy and disease activity in Danish women with multiple sclerosis: A population-based cohort study
    Kopp, Tine Iskov
    Lidegaard, Ojvind
    Magyari, Melinda
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (06) : 1753 - 1762
  • [4] Hormone replacement therapy and disease activity in Danish women with multiple sclerosis - a population-based cohort study
    Kopp, T. I.
    Lidegaard, O.
    Magyari, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 237 - 238
  • [5] Statins and risk of amyotrophic lateral sclerosis: Danish population-based cohort study
    Skajaa, Nils
    Bakos, Istvan
    Horvath-Puho, Erzsebeth
    Henderson, Victor W.
    Lash, Timothy
    Sorensen, Henrik Toft
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 120 - 120
  • [6] Association of type 1 diabetes and school wellbeing: a population-based cohort study of 436,439 Danish schoolchildren
    Eriksen, Tine M.
    Gaulke, Amanda
    Thingholm, Peter R.
    Svensson, Jannet
    Skipper, Niels
    DIABETOLOGIA, 2020, 63 (11) : 2339 - 2348
  • [7] A population-based cohort study suggests an increased risk of multiple sclerosis incidence in patients with type 2 diabetes mellitus
    Hou, Wen-Hsuan
    Li, Chung-Yi
    Chang, Hsin-Hui
    Sun, Yu
    Tsai, Chiang-Chin
    JOURNAL OF EPIDEMIOLOGY, 2017, 27 (05) : 235 - 241
  • [8] Association of type 1 diabetes and school wellbeing: a population-based cohort study of 436,439 Danish schoolchildren
    Tine M. Eriksen
    Amanda Gaulke
    Peter R. Thingholm
    Jannet Svensson
    Niels Skipper
    Diabetologia, 2020, 63 : 2339 - 2348
  • [9] Type 2 diabetes, obesity, and risk of amyotrophic lateral sclerosis: A population-based cohort study
    Skajaa, Nils
    Riahi, Emil Bjerregaard
    Szepligeti, Szimonetta Komjathine
    Horvath-Puho, Erzsebet
    Sorensen, Trine Toft
    Henderson, Victor W.
    Sorensen, Henrik Toft
    BRAIN AND BEHAVIOR, 2023, 13 (06):
  • [10] Risk of epilepsy in type 1 diabetes mellitus: a population-based cohort study
    Chou, I-Ching
    Wang, Chung-Hsing
    Lin, Wei-De
    Tsai, Fuu-Jen
    Lin, Che-Chen
    Kao, Chia-Hung
    DIABETOLOGIA, 2016, 59 (06) : 1196 - 1203